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Graphical Abstract: 
 
 
Highlights: 
 Mesoporous silica nanoparticles (MSNs) were functionalized with hyaluronic acid (HA). 
 DLS and ELS were used to characterize the hydrodynamic diameter and zeta potential of 
MSN-HA samples. 
 Cell uptake of MSN-HA on HeLa cells was investigated through optical microscopy and 
TEM. 
 The length of HA chain affects the internalization of MSN-HA on HeLa cells. 
 
 
ABSTRACT  
Mesoporous silica nanoparticles (MSNs) were functionalized with amino groups (MSN-NH2) and 
then with hyaluronic acid, a biocompatible biopolymer which can be recognized by CD44 receptors 
in tumor cells, to obtain a targeting drug delivery system. To this purpose, three hyaluronic acid 
samples differing for the molecular weight, namely HAS (8 -15 kDa), HAM (30-50 kDa) and HAL 
(90-130 kDa), were used. The MSN-HAS, MSN-HAM, and MSN-HAL materials were characterized 
through zeta potential and dynamic light scattering measurements at pH=7.4 and T=37°C to 
simulate physiological conditions. While zeta potential showed an increasing negative value with 
the increase of the HA chain length, an anomalous value of the hydrodynamic diameter was 
observed for MSN-HAL, which was smaller than that of MSN-HAS and MSN-HAM samples. The 
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cellular uptake of MSN-HA samples on HeLa cells at 37°C was studied by optical and electron 
microscopy. HA chain length affected significantly the cellular uptake that occurred at a higher 
extent for MSN-NH2 and MSN-HAS than for MSN-HAM and MSN-HAL samples. Cellular uptake 
experiments carried out at 4°C showed that the internalization process was inhibited for MSN-HA 
samples but not for MSN-NH2. This suggests the occurrence of two different mechanisms of 
internalization. For MSN-NH2 the uptake is mainly driven by the attractive electrostatic interaction 
with membrane phospholipids, while MSN-HA internalization involves CD44 receptors 
overexpressed in HeLa cells.  
 
 
KEYWORDS: Mesoporous silica nanoparticles, Hyaluronic acid, cellular uptake, target system, 
optical microscopy, transmission electron microscopy. 
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1. Introduction. 
Cancer is a multifactorial widespread disease that represents a growing threat for human health [1]. 
The microenvironment of solid tumors is very similar to tissue repair sites of an injured tissue 
where activated platelets are involved in the release of vasoactive mediators, serum fibrinogen, 
growth factors, and proteins for the regeneration of a new healthy tissue. In particular epithelial and 
stromal cells are involved in a reciprocal signaling cross-talk responsible of the healing which is 
interrupted when the tissue is completely regenerated, while persists in tumor tissue allowing for the 
growth of tumor and stimulating the angiogenesis [2–4]. This phenomenon takes place in solid 
tumors when they reach 2 mm3, and causes the formation of new blood vessels [5]. Long-circulating 
nanosized drug delivery systems (NDDS) can take advantage of the abnormal vascularization of 
tumor tissues. Indeed endothelial pores have dimensions between 10 and 1000 nm, and lymphatic 
vessels in tumor tissue are absent or no-functional, hence NDDS cannot efficiently be removed and 
are retained inside the endothelial pores. This passive phenomenon is known as Enhanced 
Permeability and Retention (EPR) effect [5].    
Current therapies consist in the administration of chemotherapeutic drugs that are able to curb 
tumor growth, but these drugs are toxic for healthy cells and can produce several bad side effects  
[1,2]. In the recent years researchers widely focused on the possibility to produce site-specific drug 
nanocarriers. Several smart drug delivery systems based on functionalized liposomes [6,7], micelles 
[8], mesoporous silica nanoparticles [9–12], carbon nanotubes [13], and inorganic nanoparticles 
[14] have been engineered. These systems allow to address the drug administration to the diseased 
tissue only [5,7], thus obtaining a reduction of the toxic effects of the drug along with an increase of 
the local drug concentration, and consequently an improvement of the therapeutic efficacy [15]. 
In this context ordered mesoporous silica was used for the first time in 2001 by Vallet-Regì and co-
workers [16], and, as a result of  peculiar features such as high surface area and pore volume that 
allow for drug adsorption and controlled release, received great attention since then [10,11,17–25]. 
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Moreover, the possibility to introduce smart functional groups at the internal and/or the external 
mesoporous silica surface [9,26–28] allows to promote different types of specific interactions with 
biological entities. Focusing on mesoporous silica nanoparticles (MSNs), huge improvements were 
obtained on specific actions such as the MSNs' performance towards the sustained drug release 
[9,26–28], the reduction of toxicity, the increase of the biocompatibility [10,29,30] and cell 
internalization [31], as well as the citotoxicity towards tumor cells [32,33]. Indeed, several target 
molecules [10,17,30,34–37] and stimuli-responsive capping agents [27,34,38–41] can easily be 
grafted at the MSNs' surface. Target molecules allow the MSNs to reach the tumor tissue only 
through a molecular recognition mechanism. Then, once in the internal tissue, the stimuli-
responsive capping agent [5,34] permits the release of the drug as a response to internal (change of 
pH [42–45], temperature [46–48], redox reactions [40,49–52]) or external (irradiation with light 
[53–55], magnetic field [55–57]) stimuli. 
Hyaluronic acid (HA) is an anionic polysaccharide composed of D-glucuronic acid and N-acetyl-D-
glucosamine units linked through alternating 1,3 and 1,4 glycosidic bonds [58,59]. HA is the main 
component of the extracellular matrix of the human connective tissue and one of the most important 
components of the skin. It also occurs at high concentrations in synovial joint fluids, vitreous humor 
of eyes, hyaline cartilage, intervertebral disc nucleus, and umbilical cord [59]. In humans HA is 
synthesized in plasma membrane by membrane-bound synthase (Has) [58]. This enzyme is present 
in three different isoforms: Has1 and Has2, responsible for the synthesis of high molecular weight 
HA (~2·106 Da), and Has3, responsible of low molecular weight (<3·105 Da) [58,60,61]. HA has 
also many physiological roles related to its structure as for example regulation of water in tissues, 
lubrication, structural and space-filling properties. If modifications of HA ordered structure occur, 
the physicochemical properties, being controlled by HA's secondary and tertiary structure, also 
change, particularly the rheological behavior [58]. Furthermore HA has a very good affinity for 
CD44 receptors overexpressed in several cancer cells, property that makes it a great active tumor 
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target [2,62]. Recently HA was used to target different kinds of NDDS like HA-conjugated 
polyamidoamine dendrimers [63], micelles [64], and ceramides [65] or HA-grafted graphene 
quantum dots [66], carbon nanotubes [67,68] as well as mesoporous silica nanoparticles [69]. 
Herein the behavior of HA-grafted MSNs was investigated, focusing on the effects of the 
biopolymer’s chain length towards cell internalization. MSNs were functionalized with HA having 
different molecular weight: HAS: 8-15 kDa, HAM: 30-50 kDa and HAL: 90-130 kDa. Dynamic 
(DLS) and electrophoretic (ELS) light scattering measurements were used to characterize the 
different systems at pH=7.4 at the temperature of 37°C to simulate physiological conditions [45,70–
72]. Fluorescence and electron microscopy experiments were then performed to highlight the 
effects of the polymer’s chain length on the HA-grafted MSNs' internalization in HeLa cells. 
 
2. Materials and methods 
2.1. Chemicals 
Tetraethoxysilane (TEOS, 98%), hexadecyltrimethylammonium bromide (CTAB, > 99 %), 
anhydrous toluene (99.8 %), 3-aminopropyl-triethoxysilane (APTES, > 98 %), hydrochloride acid 
(37%), fluorescein isothiocyanate (FITC) and triethylamine (> 99 %) were purchased from Sigma-
Aldrich (Milan, Italy). NH4NO3 (> 99.9 %), NaH2PO4 (99 %), Na2HPO4 (99 %), acetic acid 
(>99.7%), NaOH (97 %), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, > 
98 %), N-hydroxysuccinimide (NHS, > 97 %) were purchased from Fluka. Hyaluronic acid sodium 
salt (HAS: 8-15 kDa, HAM: 30-50 kDa and HAL: 90-130 kDa) was purchased from Contipro 
Biotech a.s. (Czech Republic). 
 
2.2. Synthesis of amino-functionalized Mesoporous Silica Nanoparticles (MSN-NH2) 
A
CE
PT
ED
 M
AN
US
CR
IPT
7 
 
A mass of 1g of CTAB was dissolved in 480 g of Millipore water and 3.5 mL of NaOH (2 M) and 
the resulting solution was stirred at 80°C. After 2 h a volume of 10 mL of TEOS was added 
dropwise. The solution was stirred for other 2 h, and then the resulting white precipitate (MSN-T) 
was filtered under vacuum, washed with distilled water and methanol, and dried overnight at room 
temperature. The grafting of the amino group on the surface of the MSNs was carried out by 
dispersing 1 g of the MSN-T sample in 45 mL of anhydrous toluene, and then adding dropwise 0.5 
mL of APTES. The dispersion was stirred and kept at 110°C under reflux overnight. The resulting 
MSN-T-NH2 sample was collected by filtration, washed with acetone, and dried overnight at room 
temperature under vacuum. CTAB surfactant was removed by dispersing the previously synthesized 
material in 1L of a 10 mg/mL NH4NO3 solution in ethanol:water (95:5), and then stirring the 
dispersion overnight under reflux. The functionalized mesoporous silica nanoparticles (MSN-NH2) 
were recovered via filtration, washed with water and ethanol, and dried under vacuum at room 
temperature. The removal of CTAB is confirmed by the disappearance from FTIR spectra (Fig. S1) 
of the bands at 2930 cm-1 and 2840 cm-1 - assigned to asymmetric and symmetric stretching of C-H, 
respectively - the band at1490 cm-1, due to the C-H bending, and that at 1220 cm-1 assigned to the 
C-N stretching of CTAB molecule. 
 
2.3 Grafting of Hyaluronic Acid (HA) on MSN-NH2 
A mass of 0.5 g of MSN-NH2 sample was dispersed in 50 mL of millipore water. In another vessel, 
10 mL of an aqueous solution containing NHS (0.186 g) and EDC (0.113 g) were mixed with 30 
mL of an aqueous solution containing 0.060g of HA at different chain length (HAS, HAM and HAL). 
The two solutions were mixed, and the pH was adjusted to 9.0 by adding triethylamine. Finally, the 
mixture was stirred at 38°C overnight. The HA-modified MSNs (MSN-HAS, MSN-HAM and MSN-
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HAL) were collected after centrifugation, washed extensively with millipore water, and dried under 
vacuum and at room temperature overnight. 
FITC labeling of functionalized MSNs was carried out by dispersing 40 mg of MSN-NH2 or HA-
grafted MSNs (MSN-HAS, MSN-HAM and MSN-HAL) in 5 mL of a 3.75 mM FITC solution in 
ethanol. The dispersion was stirred at room temperature under dark conditions for 3h. The obtained 
yellow powder was centrifuged, washed with ethanol to remove the excess of FITC, and dried 
under vacuum. These FITC labeled MSNs were used for fluorescence microscopy. 
 
2.4. Physico-chemical characterization of functionalized MSNs 
Textural analysis was carried out on an ASAP 2020 instrument, by determining the N2 
adsorption/desorption isotherm at 77 K. Before analysis functionalized MSNs samples were heated 
at 40°C, at the rate of 1°C/min, under vacuum for 60h. The Brunaeur-Emmett-Teller (BET)[73] and 
Barrett-Joyner-Halenda (BJH)[74] methods, calculated from adsorption and desorption branch of 
N2 isotherm, were used to calculate surface area, pore volume and pore size distribution, 
respectively.  
Small-angle X-ray scattering (SAXS) patterns were recorded through a S3-MICRO SWAXS 
camera system (HECUS X-ray Systems, Graz, Austria). CuKα radiation of wavelength 1.542 Å was 
provided by a GeniX-X-ray generator, operating at 30 kV and 0.4 mA. A 1D-PSD-50M system 
(HECUS X-ray Systems, Graz, Austria) containing 1024 channels of width 54.0 μm was used for 
detection of scattered X-rays in the small-angle region. The working q-range (Å−1) was 0.003 ≤ q ≤ 
0.6, where q (=4πsinθ λ−1) is the modulus of the scattering wave vector andθ is the scattering angle. 
Thin-walled 2 mm glass capillaries were filled with the sample for the scattering experiments. The 
scattering patterns were recorded for 1 h. 
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Thermogravimetric analysis (TGA) was carried out on a TG-DTA 320 Seiko thermo-balance. 
Thermal analysis data were collected in the 25−1000 °C range, under oxygen flow (heating rate = 
10 °C·min−1; flow rate = 50 mL·min−1). 
The hydrodynamic diameter (dH) and the zeta potential () of MSNs were measured using a 
Zetasizer Nano ZSP (Malvern Instruments) in backscatter configuration (θ =173°), at laser 
wavelength of λ = 633 nm. The scattering cell temperature was fixed at 37°C, and the data were 
analyzed with the Zetasizer software 7.03 version. For both dH and  measurements the sample was 
prepared by suspending MSNs (1 mg/mL) in filtered (0.2 m polypropylene filter, Whatman) 
milliQ water, 25 mM phosphate buffer (pH 7.4). Samples were sonicated for 30 min and left under 
stirring overnight. The samples were sonicated for other 30 min and then the measurements were 
carried out. -potential values were calculated by mean of the Henry equation [75]: 
µ𝐸 =  
2𝑓(𝑘𝑎)
3
                  (1) 
where E is the electrophoretic mobility,  is the viscosity of the dispersant, and f(a) the Henry’s 
function, (=0r) is water permittivity and 0 (= 8.85 pF/m) is vacuum permittivity. For our 
experiments we assumed as dispersant water (r = 78.5 at 25 °C and 74.40 at 37 °C, and  = 0.89 cP 
at 25°C and 0.69 cP at 37 °C) and f(a)=1.5 in agreement with Smoluchowski approximation 
commonly used for nanoparticles larger than 0.2 m dispersed in aqueous media and with 
electrolytes concentration higher than 10 mM. 
Fourier transform infrared (FTIR) studies were carried out with a Bruker Tensor 27 
spectrophotometer equipped with a diamond-ATR accessory and a DTGS detector. A number of 
256 scans at a resolution of 2 cm−1 were averaged from wave number 4000 to 400 cm−1. The Opus 
software was used for data handling. 
 
2.5. Biological assays 
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The human cervical carcinoma HeLa cell line and 3T3 murine fibroblasts (kindly provided by Dr. 
A. Diana, University of Cagliari) were grown in DMEM medium supplemented with 10% fetal 
bovine serum (FBS), 2mM L-Glutamine,  penicillin (100U/mL) and streptomycin(100µg/mL) at 
37°C in 5% CO2. 
Cell Growth was evaluated culturing 3×104/mL Hela cells in 12 well plates. The day after (t = 0) 
cells were treated with 50 μg/mL of MSN-NH2, and with HA-modified MSNs (MSN-HAS, MSN-
HAM and MSN-HAL). After 24 h nanoparticles  were removed, and cells were cultured  with fresh 
medium. Cell counts were performed immediately (t = 24  h),  after 24 (t = 24 h + 24 h) and 48 (t = 
24 h + 48 h) hours following  nanoparticles removal, using a Scepter Cell Counter, Millipore. All 
the experiments  were performed at least in triplicate for each group. 
For fluorescence microscopy, HeLa cells were grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM; Sigma Aldrich) supplemented with fetal calf serum (10%) at 37°C in a humidified 
atmosphere containing 5 % CO2. Cells were seeded in 3 cm dishes containing glass coverslips at a 
density of 1×105/ mL , left to grow for 24 h, and then incubated  with 50 µg/mL FITC-MSN-NH2 or  
FITC-MSN-HAx, where x = L (long), M (medium), and S (short) HA chain, for varying times (4 
and 24 h) either at 37°C or 4°C. After incubation, the cells were washed with PBS to remove 
unbound nanoparticles, fixed with paraformaldehyde (4%), stained with the nuclear dye Hoechst 
33342 and observed through a fluorescence microscope  (Olympus BX41) or processed for 
immunocytochemistry. 
For immunocytochemistry assay, cells on coverslips were pre-incubated with normal goat serum 
(1:5, Vector, Burlingame, CA, USA) for 30 min. Cells were then overlaid for 60 min at room 
temperature with the mouse anti-CD44 antibody (1:200, Chemicon). Then the cells were washed 
three times with PBS and subsequently incubated for 1h with an anti-mouse IgG conjugated with 
Alexa Fluor 594 (1:500, Molecular Probes). Nuclei were counterstained with Hoechst 33342. 
Negative controls were routinely performed for each experiment, incubating the samples with non-
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immune serum and then with appropriate secondary antibody. Imaging was carried out using an 
Olympus BX41 fluorescence microscope. 
A quantitative determination of the cellular uptake was provided by flow cytometry measurement. 
HeLa cells (1×105/mL) seeded in 6 cm plates were grown for 24 h and then treated with FITC-
MSN-NH2 or  FITC-MSN-HA (HAS, HAM, HAL) for 4 h either at 37°C or 4°C. After incubation, 
the cells were washed with PBS, harvested by trypsinization, suspended in PBS and analyzed by a 
flow cytometer FACSCANTO flow cytometer (BD-Bioscience) and analyzed with FACSDiva 
software Version 6.1.3 (BD Biosciences) and FloJo V7.6.5 software. 
MSNs internalization was also visualized through Transmission Electron Microscopy. Samples of 
HeLa cells, incubated with MSN-NH2, and with HA-modified MSNs (MSN-HAS, MSN-HAM and 
MSN-HAL) for 24 h at 37°, were fixed for 2 hours in a solution of 1% (para)formaldehyde (Electron 
Microscopy Sciences) and 1.25% glutaraldehyde (Electron Microscopy Sciences) in 0.1 M sodium 
cacodylate (Electron Microscopy Sciences) buffer, at  pH 7.4. After rinsing in the same buffer after 
fixation, samples were postfixed in 1% osmium tetroxide for 1 h and stained in aqueous uranyl 
acetate 0.25% overnight at 4°C. Dehydration of cell cultures  in a ascending graded series of 
ethanol and xylene was followed by infiltration and embedding in Epon 812 resin. The specimens 
were transferred to flat embedding molds and polymerized in an oven at 60 °C for 24 h. Finally, 
thin sections (60-90 nm thick) were cut with a LKB ultratome 8800 ultramicrotome, post-stained 
with uranyl acetate and bismuth subnitrate, observed and photographed in a transmission electron 
microscope (JEOL 100S model, Tokyo, Japan) operating at 80 kV. 
 
3. Results and discussion 
Functionalized MSNs, prepared according to methods described in the previous section, were firstly 
characterized for their structural, textural and surface properties through TEM, SAXS, N2 
adsorption isotherms, along with FTIR, TGA, DLS and ELS experiments. Then, to evaluate 
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biocompatibility and cell internalization performance, biological assays on HeLa cells were 
performed using image techniques, namely optical and electron microscopy. 
 
3.1. Characterization of functionalized MSN samples 
A TEM micrograph of MSNs is shown in Fig. 1A. The particles are almost spherical and display, as 
expected, parallel pore channels. The SAXS patterns of MSN-NH2, MSN-HAS, MSN-HAM and 
MSN-HAL, shown in Fig. 1B, are typical of hexagonal structures, displaying an intense peak due to 
reflection of (100) plane and two weak peaks due to the reflection of (110) and (200) planes, 
respectively. This result confirms that the functionalization preserves the original ordered structure 
of the materials. The lattice parameters, calculated using the usual equation aHex = 
(2/30.5)×(h2+k2+l2)0.5, are reported in Table 1. The N2 adsorption/desorption isotherms of MSNs 
materials are reported in Fig. 1C. They exhibit the typical trend of type IV isotherms, with a sharp 
increase of gas volume adsorption at relative pressure values in the range 0.2 - 0.4 p/p°. Table 1 
reports also the data of surface area (SBET), pore diameter (dBJH) and pore volume (VpBJH), whereas 
Fig. S2A shows the pore size distribution obtained for the functionalized materials. The FTIR 
spectra reported in Fig. 1D for the same samples show the characteristic peaks of silica materials, 
two peaks at 1060 cm-1 and 800 cm-1 due to the asymmetric and symmetric stretching vibration of 
Si-O-Si, respectively, and other two at 450 cm-1 and 960 cm-1 that can be related to O-Si-O bending 
and Si-OH stretching, respectively [76,77]. Surface functionalization is confirmed by the presence 
of two peaks at 1530 and 1640 cm-1 that are related to -NH2 bending [78] and C=O stretching [79] 
for NH2- and HA-modified MSNs, respectively. Concerning the peak at 1640 cm
-1, it cannot be 
excluded that it could also be due to the C=O stretching of NHS used to activate the -COOH groups 
of HA. Nonetheless, NHS is soluble in water and its excess has likely been fully removed during 
the last synthesis step where an extensive washing of the sample was carried out. In any case the 
functionalization of MSN-NH2 with HA is confirmed by TGA and ELS measurements as described 
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below. Fig. S2B displays the percentage mass loss as a function of temperature for functionalized 
MSNs. Values of mass loss below and above 200°C are reported in Table 1. For temperature below 
200°C mass loss is due to the removal of humidity and to the condensation of surface silanols. More 
interesting are the results at temperature above 200°C when organic groups are burnt, although the 
mass loss measured for MSN-HAL is relatively low compared to those found particularly for MSN-
HAM sample. 
 
 
 
 
Figure 1 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
14 
 
3.2. Electrophoretic (ELS) and dynamic (DLS) and light scattering measurements  
The functionalized MSNs materials were also characterized through electrophoretic light scattering 
(ELS) (Fig. S2C) and dynamic light scattering DLS (Fig. S2D) measurements to highlight the 
effects of the external functionalization. As reported in Table 1and in Fig. S2C,  values change as a 
result of the functionalization with the biopolymer. Indeed the positive value obtained for MSN-
NH2 (+34 mV) becomes negative for MSN-HA systems, due to the presence of carboxylic groups 
in the biopolymer’s chain. Furthermore  values become more negative with increasing the length 
of HA’s chain, and then the number of dissociated carboxylic groups as demonstrated by the basic 
pH values. From DLS measurements we would expect an increase, of the particle's size, dH, (Table 
1, and Fig. S2D) along the series: MSN-NH2 < MSN-HAS < MSN-HAM < MSN-HAL. In fact, dH  
increased going from MSN-NH2 (160±6 nm) to MSN-HAS (192±15 nm), but remained unchanged 
for MSN-HAM (197±8 nm), and decreased for MSN-HAL (168±11 nm) as obtained through DLS 
analysis. The increase of biopolymer chain length, going from HAS (MW = 8-15 kDa) to HAM 
(MW = 30-50 kDa), and to HAL (MW = 90-130 kDa) increases the probability of a multi-point 
attachment of HA on MSN-NH2 which simply does not allow the full disentanglement of the 
biopolymer chain. This is likely the reason of the counterintuitive trend of measured dH values. 
However, independently of the hydrodynamic diameter and HA's MW, all grafted-HA MSNs 
produce the inversion of the zeta potential. This was  = +34 mV for MSN-NH2 and became 
negative for MSN-HA samples ( = - 11, -17, -20 mV for short, medium, and long HA) paralleled 
by a strong increase of pH (from 4.2 to 8.5-8.7), as a result of a high number of dissociated 
carboxylic groups. The long biopolymer chains of HAL, multi-point attached and entangled over the 
MSN-NH2 surface may produce a thick layer that increases the negative , but does not enlarge the 
average particle's diameter of MSN-HAL sample significantly.  
In the perspective of using MSNs in biological media, the observation that HA grafting on the 
MSN-NH2 surface produces a strong effect on the pH of the aqueous dispersions of the 
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functionalized MSNs, suggested to deepen the characterizations evaluating the effect of pH using a 
pH buffer, at 37°C. The functionalized MSNs suspended in water, 25 mM phosphate buffer at 
pH=7.4 (PhB) were examined at 37°C through ELS and DLS. The results are presented in Fig. 2 
and Table S1. 
 
Figure 2  
 
As expected in water medium at 37 °C,  values are positive for MSN-NH2 and negative for MSN-
HA systems, being the values very similar to those determined at 25 °C. In phosphate buffer at pH 
7.4 all functionalized MSNs display negative values of  , being the  values increasingly negative 
according to the following sequence: -NH2 < -HAS < -HAM < -HAL. Comparing these values to 
those measured in water a significant adsorption of the H2PO4
- and HPO4
2- anions at the solid 
surface can be suggested not only for MSN-NH2 (that is expected as a result of strong electrostatic 
interactions induced particularly by divalent HPO4
2- anions), but also for HA-grafted MSNs (see  
values in Table S1): in the latter case the adsorption of buffer anions is likely due to specific 
interactions originated by van der Waals (non-electrostatic) forces [80–82]. Turning the attention to 
the particles' size dH determined through DLS (see Fig. 2B) we may remark the rather high standard 
deviations of the obtained values (Table S2). Again we observe the apparently anomalous dH values 
measured for MSN-HAL in both media (water, PhB at pH=7.4), as in the case of data at 25°C, 
reported in Table S1.  
 
3.3 Optical microscopy 
 
To evaluate the cellular uptake, HeLa cells were treated with FITC-conjugated MSN-HA particles 
and studied by fluorescence microscopy and cytofluorimetry. As shown in Fig. 3, after 4h of 
treatment at 37°C, all MSN particles were internalized by cells. In particular, MSN-HA uptake is 
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likely mediated by CD44 receptors, that are highly expressed in HeLa cells, as shown in Fig. 3. In 
fact, when a similar experiment was performed at 4°C, nanoparticles were not internalized, 
suggesting that an ATP-dependent endocytosis is involved in MSN-HA uptake which is relatively 
inactive at low temperatures (Fig. 3) [83]. On the other hand, when HeLa cells were incubated with 
MSN-NH2 at 4°C, a strong fluorescence was observed on the surface of cells, likely due to an 
attractive interaction between positively charged nanoparticles and negatively charged 
phospholipids of cell membrane (Fig. 3)[84]. 
 
Figure 3 
 
Moreover, we compared the cell internalization of MSN-HA in HeLa cells and in a  CD44 receptor-
negative cell line (3T3 cells). In contrast to HeLa, the rate of MSNs internalization was very low in 
3T3 cells after 4 hours incubation with MSN- HAS (Fig. S3), as already observed by Zhao et al. [83] 
and Wang et al. [85]. This highlights the importance of CD44 receptors to mediate cell uptake. On 
the other hand, our previous results showed MSN-HA uptake by 3T3 after 24h incubation [29], 
suggesting that alternative internalization mechanisms may take place in these cells following 
prolonged  MSN-HA exposure. 
A quantitative evaluation of the cellular uptake was provided by cytofluorimeter analysis that 
confirmed results obtained by microscopy (Fig. S4). In addition, cytofluorimetry showed a different 
rate of internalization, since MSN-NH2 and MSN-HAS particles were internalized by all cells, 
whereas both MSN-HAM and MSN-HAL were detected only in about 50% of cells. These 
differences were detected also by fluorescence microscopy after 24h treatment (Fig. S5). MSN 
particle internalization does not affect cell growth and proliferation as indicated by cell count 
results (Fig. S6). 
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3.4 Electron microscopy 
TEM experiments highlighted a well preserved ultrastructure of HeLa cells after treatment with 
MSN particles, being mainly characterized by the presence of a well-developed Golgi apparatus, 
endoplasmic reticulum and several mitochondria in their cytoplasm. TEM observations confirmed 
the fluorescence microscopy results, highlighting the presence of functionalized MSNs in the 
cytoplasm of the HeLa cells after treatment with all types of particles (Fig. 4) [31,86].  No MSNs 
were detected in the nuclear compartment (Fig. 4).  
 
Figure 4 
 
The MSNs were found confined within cytoplasmic vesicles delimited by a single membrane, 
suggesting an endocytosis process for all types of functionalized particles. This mechanism of 
internalization was proposed also by Guo and co-workers [87] which explained how particle size 
can affect the mechanism and the rate of cellular internalization. Indeed, MSNs with dimensions 
around 200 nm are easily internalized with an endocytosis process. However, differences 
concerning the amount of internalized MSNs were observed. In detail, the HeLa cells following the 
MSN-NH2 and MSN-HAS treatment exhibited the larger amount of internalized MSNs and cell 
surface interacting MSNs (Fig. 4 A-D), whereas only few internalized MSNs were observed 
following MSN-HAM, and MSN-HAL exposure (Fig. 4 E-H). Interestingly, a higher association of 
MSN-NH2 to the cellular surface was observed (Fig. 4 B).  
The Optical microscopy and TEM results indicate that two different internalization mechanisms 
occur for MSN-NH2 and MSN-HA samples. Indeed, while for MSN-NH2 the uptake is mediated by 
the electrostatic attraction between the positive surface charge of the material and the negatively 
charged cell membrane, for MSN-HA samples the uptake is likely mediated by CD44 receptors 
overexpressed in HeLa cells (Fig. 3). Indeed, the MSN-HA internalization process occurred at 37°C 
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only, whereas is inhibited at 4°C, likely due to the inactivation of the ATP-dependent endocytosis at 
low temperature (see Fig.s 3-4). 
 
4. Conclusions 
In this work the behavior of different MSNs samples, functionalized with amino groups and HA 
with increasing chain length (HAS > HAM > HAL), was investigated. They showed different  and 
hydrodynamic diameter in distilled water and at pH 7.4. We found an apparently anomalous dH 
value of MSN-HAL, which was smaller than values obtained for the other samples (MSN-HAS and 
MSN-HAM). These smaller dH values observed for MSN-HAL are likely due to the high MW and 
possible multi-point attachment of HA chains entangled over the solid surface [88]. The 
internalization of MSNs samples on HeLa cells was then evaluated. Cells were incubated at 37°C 
and 4°C with the MSNs and visualized through optical and electron microscopy. The image 
findings suggest important details on the internalization mechanism driven by the ATP-dependent 
endocytosis, and also by CD44 receptors in the case of HA functionalized MSNs. Remarkably, 
MSN-NH2 adsorbs at HeLa surface (Fig. 3A) also at low temperature because of a favorable 
electrostatic interaction. Finally, the chain length has also an effect on internalization efficiency 
since this was high for MSN-HAS and low for MSN-HAL. This is a relevant finding which is 
important for the realization of targeting drug delivery systems for cancer treatment.  
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Figures: 
 
 
       
Fig. 1 Characterization of Functionalized MSNs: (A) TEM micrographs, (B) SAXS pattern, (C) N2 
Adsorption/desorption isotherms, and (D) FTIR spectra obtained for functionalized MSNs. 
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Fig. 2 Functionalized MSNs suspended in water and phosphate buffer PhB at pH 7.4. (A) 
Zeta potential and (B) hydrodinamic diameter, at 37°C. 
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Fig. 3. Fluorescence microscopy images of HeLa cells treated for 4 h at different temperatures (4°C 
and 37°C) with FITC labeled MSN. Cell membranes are immunostained with CD44 antibody (red) 
and nuclei are stained with Hoechst (blue). Bar: 20 µm. 
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Fig. 4 Electron micrographs of HeLa cells incubated for 24h: (A-B) MSN-NH2, (C-D) MSN-HAS, 
(E-F) MSN-HAM, (G-H) MSN-HAL. Black arrows show the presence of the internalized MSNs. (B) 
Detail of cytoplasmic portion of HeLa cell displaying intense MSN-NH2 interaction with the 
external cellular surface (red arrowheads). 
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Tables: 
 
Table 1. Characterization of functionalized MSNs. Surface area (SBET), pore diameter (dBJH), pore 
volume (Vp), and lattice parameter (a) of Functionalized MSNs.  TGA measurements: mass loss 
(%). pH, zeta potential (ζ) values from ELS, and hydrodynamic diameters (dH) from DLS (in milliQ 
water at 25°C). 
 
Sample aSBET 
(m2/g) 
bdDes,BJH 
(Å) 
cVpDes,BJH 
(cm3/g) 
da 
(Å) 
eMass 
loss 
(%) 
fMass 
loss (%) 
pH   eζ (mV) edH 
(nm) 
MSN-
NH2 
805 23.0 0.64 47.0 
10.2 12.0 4.23 +34±1 160±6 
MSN-
HAS 
753 21.3 0.75 45.2 
8.0 12.1 8.65 
-
11.3±0.2 
192±15 
MSN-
HAM 
711 23.0 0.56 43.8 
7.6 17.3 8.46 -17±3 197±8 
MSN-
HAL 
735 20.6 0.83 45.4 
7.6 15.7 8.73 
-
20.4±0.7 
168±11 
aSurface area calculated by the BET method. bPore diameter from the desorption branch calculated 
by BJH method. cPore volume from the desorption branch calculated at p/p°=0.99 by BJH method. 
dLattice parameter obtained by SAXS. eT < 200°C. fT>200°C. eReported values are the average of 
at least three measurements. 
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